| Expression pattern: |
UP |
| Associated gene: |
ETV4, AGO2 |
| Associated microRNA: |
miR-330-5p, miR-193a-5p, miR-326 |
| Biological function: |
promotes PTC cell proliferation and tumor growth; inhibits apoptosis; promotes G1/S phase transition |
| Molecular mechanism: |
acts as a miRNA sponge for miR-330-5p, miR-193a-5p and miR-326 to upregulate ETV4 (ceRNA-like regulation) |
| Biological pathway or process: |
proliferation (promotes); apoptosis (inhibits); cell cycle (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; FISH / smFISH; RT-qPCR; Clinical Sample Validation; Transfection; CCK8; EdU Staining; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Western Blot; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); In Vivo Animal Model; IHC (Immunohistochemistry); TUNEL; Bioinformatics Analysis; Microarray |
| Clinical significance: |
Its expression was associated with lymph node metastasis of patients with PTC. |
| Description: |
hsa_circ_0001666 is up-regulated in papillary thyroid carcinoma tissues and cell lines and is associated with lymph node metastasis. It promotes PTC proliferation and tumor growth and suppresses apoptosis by sponging miR-330-5p/miR-193a-5p/miR-326 to upregulate ETV4. |
| Confidence score: |
0.8635 |